Affiner les résultats

Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)

Perey, L. ; Paridaens, R. ; Hawle, H. ; Zaman, K. ; Nolé, F. ; Wildiers, H. ; Fiche, M. ; Dietrich, D. ; Clément, P. ; Köberle, D. ; Goldhirsch, A. ; Thürlimann, B.

In: Annals of Oncology, 2006, vol. 18, no. 1, p. 64-69